Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents-Reference-Cited by-同舟云学术

Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents

Published:2022-05 Issue:3 Volume:42 Page:238-246
ISSN:1533-712X
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:J Clin Psychopharmacol

Author:

Mohamoud Mohamed,Chen Qi,Croteau David,Cheng Carmen,Burkhart Keith,Volpe Donna A.,Kortepeter Cindy,Demczar Dorothy,Stone Marc

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference42 articles.

1. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016;J Clin Child Adolesc Psychol,2018

2. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents;Pediatrics,2019

3. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology;J Psychopharmacol,2014

4. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007;J Am Acad Child Adolesc Psychiatry,2010

5. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009;J Child Adolesc Psychopharmacol,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Dystonic Reaction Following Methylphenidate Discontinuation During Combination Therapy with Risperidone: A Case Study;Journal of Ankara University Faculty of Medicine;2024-08-13

2. A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders;Expert Opinion on Pharmacotherapy;2023-06-21

3. Multiple drugs;Reactions Weekly;2023-06-10

4. Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden;Neuro-/Psychopharmaka im Kindes- und Jugendalter;2023

5. Should Antipsychotic Medications Be Prescribed to Patients With Nonpsychotic Depression?;Journal of Clinical Psychopharmacology;2022-04-19